Biologics represent a breakthrough for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). But with high non-response rates and other unresolved issues, researchers are exploring how best to put these therapies to work, panelists said in a session at the Triological Society Combined Sections Meeting.
ETI has been shown to have positive effects on multiple organ systems in cystic fibrosis patients.
What is the long-term safety and effectiveness of temperature-controlled radiofrequency neurolysis of the posterior nasal nerve in patients with chronic rhinitis?
Patients with uncontrolled chronic rhinosinusitis (CRS) demonstrate distinct patterns of olfactory impairment, and a reduced olfactory threshold is highly associated with uncontrolled CRS.
Platelet-to-lymphocyte ratio (PLR) might have a predictive value in patients with chronic rhinosinusitis with nasal polyps in terms of treatment response to dupilumab, particularly PLR above 131.2.
Many patients who have undergone a cleft rhinoplasty procedure have interest in a secondary procedure, suggesting that providers should keep in touch with patients about their surgical options as they age.
The FDA recently expanded the approval of the XHANCE fluticasone propionate nasal spray manufactured by Optinose for chronic rhinosinusitis to also include treatment of adults aged 18 and older without nasal polyps.
Unconscious associations between certain scents can affect how we perceive certain colors.
The aim of oroantral fistula management is to repair the defect, restoring the integrity of the sinus and oral cavity and preventing sinus infections.
Nasodine, an over-the-counter preparation, shows effective antibiofilm agent that is highly active against biofilms and holds promise for the management of sinonasal biofilms in CRS.